Literature DB >> 19147094

Inflammation and bone marrow transplantation.

Geoffrey R Hill1.   

Abstract

The procedural requirements of bone marrow transplantation (BMT) predispose to the dramatic induction of local and systemic inflammatory states and can be conceived in relation to transplant conditioning, the activation of alloreactive T cells and finally, the effector stage of graft-versus-host disease (GVHD). It is now clear that alloreactive T cell responses result in a dramatic and often fulminant amplification of systemic inflammation that is responsible for many of the characteristic causes of transplant-related mortality. The pathways by which inflammatory cytokines are induced after BMT and the resultant pathologies will be discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19147094     DOI: 10.1016/j.bbmt.2008.11.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  10 in total

1.  Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells.

Authors:  Cameron J Turtle; Jeff Delrow; Rochelle C Joslyn; Hillary M Swanson; Ryan Basom; Laura Tabellini; Colleen Delaney; Shelly Heimfeld; John A Hansen; Stanley R Riddell
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

2.  The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.

Authors:  Senthilnathan Palaniyandi; Reena Kumari; Sabarinath Venniyil Radhakrishnan; Ethan Strattan; Natalya Hakim; Reinhold Munker; Melissa V Kesler; Gerhard C Hildebrandt
Journal:  Transplantation       Date:  2020-12       Impact factor: 4.939

Review 3.  Links between innate immunity and normal tissue radiobiology.

Authors:  Dörthe Schaue; William H McBride
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

4.  Distinct activation thresholds of human conventional and innate-like memory T cells.

Authors:  Chloe K Slichter; Andrew McDavid; Hannah W Miller; Greg Finak; Brenda J Seymour; John P McNevin; Gabriela Diaz; Julie L Czartoski; M Juliana McElrath; Raphael Gottardo; Martin Prlic
Journal:  JCI Insight       Date:  2016-06-02

5.  Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia.

Authors:  Edward Abadir; Pablo A Silveira; Robin E Gasiorowski; Murari Ramesh; Adelina Romano; Ahmed H Mekkawy; Tsun-Ho Lo; Karieshma Kabani; Sarah Sutherland; Geoffrey A Pietersz; P Joy Ho; Christian E Bryant; Stephen R Larsen; Georgina J Clark
Journal:  Blood Adv       Date:  2020-04-14

6.  Immunomodulatory Effect of Hispolon on LPS-Induced RAW264.7 Cells and Mitogen/Alloantigen-Stimulated Spleen Lymphocytes of Mice.

Authors:  Eun Kyeong Lee; Eun Mi Koh; Yu Na Kim; Jeongah Song; Chi Hun Song; Kyung Jin Jung
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

Review 7.  Inflammasomes-New Contributors to Blood Diseases.

Authors:  Jaromir Tomasik; Grzegorz Władysław Basak
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

Review 8.  Perinatal derivatives: How to best validate their immunomodulatory functions.

Authors:  Andrea Papait; Antonietta Rosa Silini; Maria Gazouli; Ricardo Malvicini; Maurizio Muraca; Lorraine O'Driscoll; Natalia Pacienza; Wei Seong Toh; Gustavo Yannarelli; Peter Ponsaerts; Ornella Parolini; Günther Eissner; Michela Pozzobon; Sai Kiang Lim; Bernd Giebel
Journal:  Front Bioeng Biotechnol       Date:  2022-09-14

9.  Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats.

Authors:  Qingzhen Gao; Xiaoping Wang; Ruibin Zhang; Pu Wang; Yongsheng Jing; Wanjun Ren; Bin Zhu
Journal:  J Diabetes Investig       Date:  2016-01-23       Impact factor: 4.232

Review 10.  The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.

Authors:  Margherita Boieri; Pranali Shah; Ralf Dressel; Marit Inngjerdingen
Journal:  Front Immunol       Date:  2016-08-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.